THYROID CANCER
Clinical trials for THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER trials appear
Sign up with your email to follow new studies for THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy trial offers hope for aggressive thyroid cancer
Disease control OngoingThis study is testing whether the immunotherapy drug pembrolizumab (Keytruda) can help control advanced anaplastic thyroid cancer, a rare and aggressive form of the disease. The trial includes 12 adults with cancer that cannot be surgically removed or has spread, and who have no …
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Zapping tiny thyroid tumors: laser test aims to avoid surgery
Disease control OngoingThis study is testing whether using a laser to heat and destroy very small thyroid cancers is a safe and effective alternative to surgery. It will involve 10 patients who have a tiny papillary thyroid cancer but do not want to just watch and wait. Doctors will use a needle to gui…
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New Two-Drug attack on Tough-to-Treat head and neck cancers
Disease control OngoingThis study is testing whether combining an immunotherapy drug (pembrolizumab) with a chemotherapy drug (docetaxel) can help control advanced thyroid and salivary gland cancers that have stopped responding to standard treatments. It will involve about 46 adults with these specific…
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Major cancer trial tests new hope for patients Who've run out of options
Disease control OngoingThis study tested pembrolizumab, an immunotherapy drug, in people with advanced solid tumors who had already tried standard treatments that stopped working. Researchers enrolled 1,609 participants with various cancers including anal, cervical, lung, and thyroid cancers to see how…
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Targeted drug trial aims to shrink inoperable thyroid tumors before surgery
Disease control OngoingThis study is testing if a drug called vemurafenib can shrink thyroid tumors before surgery in patients with advanced cancer. The drug targets a specific genetic mutation found in the cancer cells. Researchers will measure changes in tumor size and certain biomarkers after 56 day…
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo targets tough thyroid cancers
Disease control OngoingThis study is testing whether combining an immunotherapy drug called PDR001 with other targeted cancer drugs is safe and effective for treating advanced thyroid cancer that no longer responds to standard radioactive iodine treatment. The trial includes 19 adults with specific typ…
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Do thyroid cancer patients need extra neck surgery? major trial seeks answers
Disease control OngoingThis study compares two surgical approaches for low-risk thyroid cancer to determine which leads to better long-term outcomes. Patients with early-stage thyroid cancer were randomly assigned to receive either standard thyroid removal alone or thyroid removal plus additional lymph…
Matched conditions: THYROID CANCER
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Targeted drug tested for Tough-to-Treat thyroid cancer
Disease control OngoingThis study is testing whether the drug regorafenib can help control metastatic medullary thyroid cancer that has continued to grow despite prior treatments. It is for adults whose cancer has worsened within the last 6 months and who have already tried at least one other targeted …
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New test could spare thyroid patients unnecessary surgery
Diagnosis OngoingThis study aims to validate a new molecular test to better determine if thyroid nodules are cancerous. It involves 71 patients with inconclusive biopsy results. The goal is to improve diagnosis so fewer people undergo surgery for benign nodules.
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
AI doctors: smart ultrasound aims to spot thyroid problems faster
Diagnosis OngoingThis study is testing whether a new artificial intelligence (AI) tool can help doctors more accurately and quickly diagnose thyroid diseases from ultrasound images. It involves 2,000 adults across 16 hospitals in China who are already getting thyroid ultrasounds for suspected pro…
Matched conditions: THYROID CANCER
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test glowing light to see inside cancer tumors
Diagnosis OngoingThis study is testing a new way to take pictures of cancer tumors using a special light called Cerenkov luminescence. The goal is to see if this method can clearly show tumors in areas like the neck, armpit, or groin. The study involves 102 adults with thyroid cancer or other can…
Matched conditions: THYROID CANCER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC
-
Could thyroid cancer scan prep affect breast tissue?
Knowledge-focused OngoingThis study aims to understand why breast tissue sometimes shows up on radioactive iodine scans in women treated for thyroid cancer. Researchers are comparing two different preparation methods for the scan to see if one affects a specific hormone (prolactin) more, and if that horm…
Matched conditions: THYROID CANCER
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Can a computer make doctors more accurate?
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing whether an artificial intelligence (AI) assistant can help medical students and doctors more accurately determine the stage and risk level of thyroid cancer from patient notes. 70 participants will review cases, with half using the AI tool and half not, to s…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Could skipping thyroid ultrasound be safe? major study investigates
Knowledge-focused OngoingThis study looks at whether patients who have a small thyroid lump found by chance during a PET scan need a follow-up ultrasound. Researchers are comparing the long-term survival rates of 5,000 people who got an ultrasound within 3 months to those who did not. The goal is to see …
Matched conditions: THYROID CANCER
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:50 UTC
-
Could thyroid surgery affect your heart health?
Knowledge-focused TerminatedThis study aimed to understand if thyroid surgery changes the thickness of neck arteries, which is linked to future heart disease and stroke risk. Researchers planned to measure artery thickness before and after surgery in adults with various thyroid conditions. The goal was to g…
Matched conditions: THYROID CANCER
Sponsor: Istituto Auxologico Italiano • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:29 UTC